Literature DB >> 12879744

Evaluation of in vitro antifungal activity of N-benzylsalicylamide derivatives.

P Kubanová1, V Buchta, M Perina, K Waisser, M Pour.   

Abstract

A series of 65 derivatives of N-benzylsalicylamide was tested against eight potentially human pathogenic fungi by microdilution broth method modified according to M27-A standard. The majority of these compounds showed only weak in vitro antifungal activity. The most significant effect was observed against filamentous fungi Trichophyton mentagrophytes, Absidia corymbifera, and Aspergillus fumigatus while yeasts, in general, were less susceptible. N-(4'-Chlorobenzyl) salicylamides, N-(3',4'-dichlorobenzyl)-salicylamides, and partially N-benzylsalicylamides exhibited relatively high in vitro antifungal activity. The most efficient derivatives had MIC < or = 7.8 mumol/L against T. mentagrophytes. Regression analysis suggested an indirect relationship between MIC values and lipophilicity (log P).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879744     DOI: 10.1007/bf02931364

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  5 in total

Review 1.  Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.

Authors:  J Bastert; M Schaller; H C Korting; E G Evans
Journal:  Int J Antimicrob Agents       Date:  2001-02       Impact factor: 5.283

Review 2.  [Biological activity of salicylanilides].

Authors:  L Kubicová; K Waisser
Journal:  Cesk Farm       Date:  1992-09

Review 3.  The exciting future of antifungal therapy.

Authors:  M N Neely; M A Ghannoum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-12       Impact factor: 3.267

4.  Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.

Authors:  M J Macielag; J P Demers; S A Fraga-Spano; D J Hlasta; S G Johnson; R M Kanojia; R K Russell; Z Sui; M A Weidner-Wells; H Werblood; B D Foleno; R M Goldschmidt; M J Loeloff; G C Webb; J F Barrett
Journal:  J Med Chem       Date:  1998-07-30       Impact factor: 7.446

5.  In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-diones.

Authors:  K Waisser; L Kubicová; V Buchta; P Kubanová; K Bajerová; L Jirásková; O Bednarík; O Bures; P Holý
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.